Navigation Links
Cynosure Announces Schedule of Upcoming Investor Conferences
Date:6/3/2008

WESTFORD, Mass., June 3 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker will discuss the company's business outlook, growth strategy and recent financial results at the following investor conferences this month:

-- On Thursday, June 12, the company will present at the 7th Annual

Needham & Company Biotechnology and Medical Technology Conference in

New York City. The presentation is scheduled to begin at 10:00 a.m.

ET.

-- On Wednesday, June 25, Cynosure will present at the Jefferies 2nd

Annual Healthcare Conference in New York City. The presentation is

scheduled to begin at 3:45 p.m. ET.

Investors interested in listening to the live webcasts of these presentations should log on to the "Investor Relations" section of Cynosure's website, http://www.cynosure.com, and click on the link labeled "Events." The presentations also will be archived on the company's website.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com.


'/>"/>
SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cynosure Appoints H. Travis Lee as Vice President of Global Marketing
2. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
3. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
4. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
5. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
6. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
7. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
8. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
9. Growing Generations Announces Surrogacy Program for Men with HIV
10. DRCs Metrigraphics Announces Family of Micro-Induction Coils for Implanted and Traditional Medical Applications
11. Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Australian-US drug discovery and ... today the appointment of a new Chairman, Mr John ... , effective immediately. James Garner , has ... Director and former Acting CEO, Mr Iain Ross , ... Director. --> James Garner , has also been ...
(Date:2/4/2016)... , ... February 04, 2016 ... ... presented by Bloomsburg University’s Digital Forensics Club, takes place February 5-6 at ... event features 20+ speakers and activities such as workshops and competitions for ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... Many of ... for over 10 years. What sets them apart from other cuvette manufacturers is ... posted on their website. On top of this steady flow of inside information, ...
Breaking Biology Technology:
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of human interface ... 31, 2015. --> --> ... percent compared to the comparable quarter last year to $470.5 million. ... million, or $0.93 per diluted share. --> ... of fiscal 2016 grew 9 percent over the prior year period ...
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ... Market 2016-2020"  report to their offering. ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the addition ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... MedNet,s significant achievements are the result of the company,s ... iMedNet eClinical , it,s comprehensive, easy-to-use and ... --> Key MedNet growth achievements in ...
Breaking Biology News(10 mins):